We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

21 hedge funds and large institutions have $494K invested in Edesa Biotech in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.8% less ownership

Funds ownership: 1.3% → 0.5% (-0.8%)

13% less funds holding

Funds holding: 24 → 21 (-3)

20% less capital invested

Capital invested by funds: $617K → $494K (-$123K)

75% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 4

Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CM
CM Management
Florida
+$439K
2
TRCT
Tower Research Capital (TRC)
New York
+$15.1K
3
Wells Fargo
Wells Fargo
California
+$12

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$74K
2
Millennium Management
Millennium Management
New York
-$63.1K
3
MFG
Merit Financial Group
Georgia
-$33K
4
UBS Group
UBS Group
Switzerland
-$1.87K
5
AC
Armistice Capital
New York
-$1.65K
Name Holding Trade Value Shares
Change 		Change in
Stake
CM
1
CM Management
Florida
$230K +$439K +35,714 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$102K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$75K – – –
State Street
4
State Street
Massachusetts
$22K – – –
Millennium Management
5
Millennium Management
New York
$16K -$63.1K -5,125 -67%
Dimensional Fund Advisors
6
Dimensional Fund Advisors
Texas
$16K – – –
Northern Trust
7
Northern Trust
Illinois
$14K – – –
TRCT
8
Tower Research Capital (TRC)
New York
$11K +$15.1K +1,229 +245%
National Bank of Canada
9
National Bank of Canada
Quebec, Canada
$4K – – –
TWC
10
TD Waterhouse Canada
Ontario, Canada
$1.1K – – –
Fifth Third Bancorp
11
Fifth Third Bancorp
Ohio
$1K – – –
Morgan Stanley
12
Morgan Stanley
New York
$1K – – –
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$1K – – –
FDCDDQ
14
Federation des caisses Desjardins du Quebec
Quebec, Canada
$124 – – –
AC
15
Armistice Capital
New York
– -$1.65K -146,182 Closed
Renaissance Technologies
16
Renaissance Technologies
New York
– -$74K -6,607 Closed
MFG
17
Merit Financial Group
Georgia
– -$33K -2,916 Closed
UBS Group
18
UBS Group
Switzerland
– -$1.87K -152 -97%
Wells Fargo
19
Wells Fargo
California
– +$12 +1 +10%

EDSA Hedge Fund Activity: Q3 2022 in Review

21 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q3 2022, worth a combined $494K — down 20% from $617K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of EDSA and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was CM Management, opening a new position worth an estimated $439K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $74K sold.

  • 21 institutional investors held Edesa Biotech (EDSA) as of Q3 2022, down from 24 in Q2 2022.
  • Funds reported $494K of Edesa Biotech stock for Q3 2022, down 20% quarter-over-quarter.
  • 1 fund opened new Edesa Biotech positions in Q3 2022 and 4 closed out, a net change of -3 holders.
  • The largest Edesa Biotech buyer in Q3 2022 was CM Management, an estimated $439K added.
  • The largest Edesa Biotech seller in Q3 2022 was Renaissance Technologies, an estimated $74K sold.

Based on aggregated 13F filings for Q3 2022.